American Heart Journal
Volume 148, Issue 1 , Pages 7-15, July 2004

Coronary artery disease in the developing world

  • Karen Okrainec, MSc

      Affiliations

    • Department of Epidemiology and Biostatistics, McGill University, Montreal, Quebec, Canada
  • ,
  • Devi K Banerjee, MD

      Affiliations

    • Department of Internal Medicine, Jewish General Hospital, McGill University, Montreal, Quebec, Canada
  • ,
  • Mark J Eisenberg, MD, MPH

      Affiliations

    • Divisions of Cardiology and Clinical Epidemiology, Jewish General Hospital, McGill University, Montreal, Quebec, Canada
    • Corresponding Author InformationReprint requests: Mark J. Eisenberg, MD, MPH, Divisions of Cardiology and Clinical Epidemiology and Associate Professor of Medicine, Jewish General Hospital/McGill University, 3755 Cote Ste. Catherine Road/Suite A-118, Montreal, Quebec, Canada H3T 1E2.

Received 9 April 2003; accepted 11 November 2003.

Abstract 

Background

Coronary artery disease (CAD) is the leading cause of cardiovascular mortality worldwide, with >4.5 million deaths occurring in the developing world. Despite a recent decline in developed countries, both CAD mortality and the prevalence of CAD risk factors continue to rise rapidly in developing countries. The objectives of the current article are to review (1) the literature regarding CAD mortality and the prevalence of CAD risk factors in the developing world, and (2) prevention and control measures.

Methods

We conducted a MEDLINE search of the English language literature for the years 1990 to 2002 to identify articles pertaining to the prevalence of CAD in developing countries. The search was performed using the following key terms: coronary artery disease, developing countries, ischemic heart disease, incidence, prevalence, prevention and risk factors. We also obtained relevant statistical information from The World Health Organization's Internet database.

Results

There is a paucity of data regarding CAD and its prevalence in the developing world. However, it is projected that CAD mortality rates will double from 1990 to 2020, with approximately 82% of the increase attributable to the developing world. Existing data suggest that rapid socioeconomic growth in developing countries is increasing exposure to risk factors for CAD, such as diabetes, genetic factors, hypercholesterolemia, hypertension, and smoking. There is a relative lack of prevention and control measures to decrease exposure to these risk factors in developing countries.

Conclusion

Documented information on the prevalence of CAD in developing countries is sparse, but there is sufficient data to suggest an impending epidemic. Prevention and targeted control of risk factors for CAD could potentially reduce the impact of CAD in the developing world as it has in industrialized nations.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0002-8703(04)00204-2

doi:10.1016/j.ahj.2003.11.027

American Heart Journal
Volume 148, Issue 1 , Pages 7-15, July 2004